multiple sclerosis Archive - ms-mcs https://www.ms-mcs.ch/category/multiple_sclerosis/ Medical communication, medical affairs and commercialization services Thu, 19 Oct 2023 10:56:32 +0000 de hourly 1 https://wordpress.org/?v=6.4.10 https://www.ms-mcs.ch/wp-content/uploads/2020/12/cropped-mcs_icon-32x32.png multiple sclerosis Archive - ms-mcs https://www.ms-mcs.ch/category/multiple_sclerosis/ 32 32 Medical Consensus https://www.ms-mcs.ch/consensus-process-biosimilars-multiple-sclerosis/ Tue, 17 Oct 2023 16:20:10 +0000 https://www.ms-mcs.ch/?p=1182

double helixConsensus process.

Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations (Mult Scler. 2022 Dec;28(14):2177-2189.). Coordination of the consensus group, contribution to the systematic literature review and the revision of the manuscript. This project was funded by unrestricted educational grants from Viatris, Synthon and GL Pharma.

]]> Vitamin D and multiple sclerosis https://www.ms-mcs.ch/vitamin-d-multiple-sclerosis/ https://www.ms-mcs.ch/vitamin-d-multiple-sclerosis/#respond Thu, 03 Dec 2020 15:29:52 +0000 https://ms-mcs.ch/?p=1

A comprehensive review.

This review was written in collaboration with Mark Rametta (Bayer, USA) and Anthony Reder (University of Chicago, USA), and published in Neurology and Therapy (Neurol Ther. 2018;7(1):59–85). The article was among the five most popular articles in 2018 and 2019, in terms of downloads from SpringerLink (Sabbagh MN & Bertolotto A. Neurol Ther. 2018) and (Sabbagh MN & Bertolotto A. Neurol Ther. 2019) This project was supported by Bayer.

]]> https://www.ms-mcs.ch/vitamin-d-multiple-sclerosis/feed/ 0 Interferon beta 1b https://www.ms-mcs.ch/interferon-beta-1b-review/ Wed, 02 Dec 2020 10:09:31 +0000 https://ms-mcs.ch/?p=358

Interferon beta 1b following natalizumab discontinuation.

One year, randomized, prospective, pilot trial (Gobbi C, Meier DS, Cotton F, Sintzel MB, et al. BMC Neurol. 2013;13:101). Support of the team at the Civico Hospital in Lugano, Switzerland, to design and conceptualize the study and revising the manuscript for intellectual content. Project supported by Bayer Switzerland.

]]>